Skip to content
Trending Topics
  • Bioelectronic Medicine: A New Frontier in Clinical Practice
  • The Quantum Cure: How Computing’s Next Frontier Could Transform Medicine
  • Private Practice, Public Shift: Why Concierge Medicine Matters Now
  • Healthcare Arbitrage: A Global Pressure Valve or an Ethical Fault Line?
  • Systemic Solutions to HCP Burnout: From Awareness to Action

21 October, 2025

  • Hot Topics
  • Technology
  • Advances in Therapy
  • Business & Healthcare
  • Health & Wellness
  • Legends
  • Hot Topics
  • Technology
  • Advances in Therapy
  • Business & Healthcare
  • Health & Wellness
  • Legends
  • Hot Topics
  • Technology
  • Advances in Therapy
  • Business & Healthcare
  • Health & Wellness
  • Legends
  • Hot Topics
  • Technology
  • Advances in Therapy
  • Business & Healthcare
  • Health & Wellness
  • Legends

Smart Doctor

Hot Topics

We are on a mission to empower healthcare professionals, researchers, and medical enthusiasts with the latest insights, innovations, and opportunities in the ever-evolving world of medicine. Our passion lies in fostering a thriving community where ideas converge, knowledge is shared, and groundbreaking advancements are made possible through collective efforts.

Hot Topics

Dalpiciclib Plus Endocrine Therapy Improves Early HR+/HER2– Breast Cancer Outcomes

This phase 3 DAWNA‑A trial (NCT04842617) was conducted to determine whether adjuvant dalpiciclib enhances survival when combined with endocrine therapy

Hot Topics

Nadunolimab Plus Chemotherapy Improves Survival in IL1RAP‑High Metastatic PDAC

The study analysis evaluated the efficacy of nadunolimab— a fully humanized Fc enhanced IgG1 monoclonal antibody targeting interleukin 1 receptor

Hot Topics

Dostarlimab–Chemotherapy Improves Quality-Adjusted and Overall Survival in Endometrial Cancer

This randomized, double‑blind, placebo‑controlled trial assessed whether adding dostarlimab to standard carboplatin–paclitaxel chemotherapy improves quality‑adjusted and overall survival in primary

Hot Topics

Avacopan Reduces Adverse Events in ANCA-Associated Vasculitis Treatment

The pooled analysis aimed to evaluate the safety profile of avacopan, a complement C5a receptor inhibitor, in patients with antineutrophil

Page1 Page2 Page3

Get Updates And Stay Connected. Subscribe To Our Newsletter.

We are on a mission to empower healthcare professionals, researchers, and medical enthusiasts with the latest insights, innovations, and opportunities in the ever-evolving world of medicine.

Quick Links

  • Privacy Policy
  • Terms & Conditions

Trending Topics

  • Hot Topics
  • Advances in Therapy
  • Health & Wellness
  • Business & Healthcare
  • Technology

lATEST NEWS

AI in Clinical Decision-Making: Hype vs. Reality

Precision Nutrition: Tailoring Diets Based on Genetic and Microbiome Profiles